A randomized controlled clinical trial for Qing-Gan Huo-Xue decoction in the treatment of alcoholic liver disease

onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged 18-70 years old;
•2. The alt, AST or ? - GT were 1.5 times higher than the normal value;
•3. Those who did not take relevant drugs within one week
•4. Those who deny that hypertension, diabetes, cardiovascular and cerebrovascular diseases need to take all kinds of Western medicine for a long time;
•5. During the study period, there was no pregnancy plan or postpartum non lactation period;
•6. Normal mental and intelligence can cooperate with the researcher;
•7. Informed consent and willing to accept the treatment plan.

•1. Other liver diseases such as hepatitis B and C were found;
•2. Those who relapsed drinking during the treatment;
•3. Those who participated in other clinical studies or used other treatment schemes during the observation period;
•4. Use other drugs by oneself during case observation;
•5. Failure to complete follow-up or withdrawal from treatment due to other reasons;
•6. During the study period, patients with severe cerebrovascular disease, hematopoietic system and mental diseases;
•7. Pregnant women during observation;
•8. Autoimmune liver disease, diabetic endocrine fatty liver disease, drug-induced liver disease, toxic hepatitis, liver cancer, nonalcoholic fatty liver disease, hepatorenal failure, occult hepatitis, liver disease with unknown causes;
•9. Allergic to polyene phosphatidylcholine and / or traditional Chinese medicine;
•10. Those who can't insist on completing the treatment or main observation indexes.

发起方

onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine